Upper gastrointestinal cancer
B143 – B155
- B143: Novel Raman probe for optical biopsy at endoscopy
- B144: Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): results of a multicentre, randomised phase III trial (the UK ABC-02 trial)
- B145: A novel small molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vivo
- B146: Loss of TGFβigh3 from gastric cancer associated myofibroblasts results in increased cancer cell migration
- B147: Pancreatic palliative chemotherapy audit across five cancer networks, SWCIS upper GI tumour group
- B148: Genomewide mRNA profiling of familial and non-familial esophageal squamous cell carcinoma for identification of molecular mechanism of esophageal cancer in high-risk area of India
- B149: Gemcitabine resistance in pancreatic cancer cell lines correlates with the expression of key proteins its uptake and metabolism
- B150: Characterisation of Cytokine-mediated crosstalk between pancreatic cancer and monocytic cells
- B151: Quality of life following ALA v Photofrin PDT for Dysplastic Barrett’s Oesophagus - preliminary results of a randomised controlled trial
- B152: The isolation and enumeration of circulating tumour cells from patients with advanced oesophageal or gastric cancer
- B153: Intensity of radical resection for gastro oesophageal junction cancer in relation to survival outcomes in England
- B154: A rare cause of hypoglycaemia in metastatic pancreatic adenocarcinoma
- B155: Screening for pancreatic cancer combining k-ras mutations in plasma and the detection of circulating tumour cells
